Novartis (NYSE: NVS) reported Q4 EPS of $1.98, $0.16 better than the analyst estimate of $1.82. Revenue for the quarter came in at $13.15 billion versus the consensus estimate of $12.99 billion.

GUIDANCE

2025 Net sales expected to grow mid- to high-single digit and core operating income expected to grow high single to low double-digit.

For earnings history and earnings-related data on Novartis (NVS) click here.